Discover the emerging class of degrader-antibody conjugates – a modality that is drawing increasing interest from biotech ...
Scientists, biochemists, and R&D leaders in pharma and biotech seeking to harness AI to drive innovation, improve efficiency, and stay ahead in drug development. He is the author of two books and 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results